In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nolvadex, Istubal, Valodex, Tamoxifen Citrate Drug Master File in Korea (Nolvadex, Istubal, Valodex, Tamoxifen Citrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nolvadex, Istubal, Valodex, Tamoxifen Citrate. The MFDS reviews the Nolvadex, Istubal, Valodex, Tamoxifen Citrate KDMF as part of the drug registration process and uses the information provided in the Nolvadex, Istubal, Valodex, Tamoxifen Citrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nolvadex, Istubal, Valodex, Tamoxifen Citrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nolvadex, Istubal, Valodex, Tamoxifen Citrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nolvadex, Istubal, Valodex, Tamoxifen Citrate suppliers with KDMF on PharmaCompass.